Skip to main content
APLM
NASDAQ Life Sciences

Apollomics Posts $8.8M H1 Loss With Just $1.0M Cash on Hand

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$18.25
Mkt Cap
$53.198M
52W Low
$10.006
52W High
$28.29
52W Position info
82% above low
Off High info
35% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

APLM sits 82% above its 52-week low of $10.006.

Summary

Apollomics reported a first-half 2026 net loss of $8.8 million, or $4.06 per share, narrower than the $12.5 million loss a year earlier, but the balance sheet is the story. Cash and equivalents stood at $1.0 million on June 30, 2026, down from $3.3 million at year-end 2025, and the company had no revenue versus $8.5 million in the prior-year period. Cost cuts drove the improvement: R&D fell to $2.0 million from $4.6 million and G&A dropped to $4.5 million from $14.5 million. The company also booked a $2.3 million expected credit loss impairment on financial assets. This follows the 6-K filed November 6 that disclosed the going-concern warning; the roughly $10.0 million private placement signed in August is the only near-term funding cushion, and insiders including the CEO and CFO bought into it at $15.00 per share.

At the time of this announcement, APLM was trading at $18.25 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $53.2M. The 52-week trading range was $10.01 to $28.29. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

APLM - Latest Insights

APLM
Nov 06, 2026, 4:15 PM EST
Filing Type: 6-K
Importance Score:
9
Price at Filing: $19.00
Real-time Price: $18.92 info
Change: -$0.080 (-0.42%) info
Market Cap: $53.198M info
APLM
Aug 17, 2026, 7:23 PM EDT
Filing Type: 4
Importance Score:
9
Price at Filing: $23.55
Real-time Price: $18.92 info
Change: -$4.63 (-20%) info
Market Cap: $53.198M info
APLM
Aug 17, 2026, 4:05 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $23.55
Real-time Price: $18.92 info
Change: -$4.63 (-20%) info
Market Cap: $53.198M info
APLM
Aug 11, 2026, 4:35 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $18.16
Real-time Price: $18.92 info
Change: +$0.760 (+4%) info
Market Cap: $53.198M info
APLM
Jul 13, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $18.95
Real-time Price: $18.92 info
Change: -$0.030 (-0.16%) info
Market Cap: $53.198M info